期刊文献+

紫杉醇+顺铂方案联合同步放疗治疗中晚期食管癌临床观察 被引量:3

Clinical observation of paclitaxel + cisplatin regimen combined with radiotherapy for advanced esophageal cancer
下载PDF
导出
摘要 目的探讨紫杉醇+顺铂方案联合同步放疗治疗中晚期食管癌的临床疗效。方法 2011年3月至2012年3月期间,本院诊治的60例中晚期食管癌患者,根据随机数字法,将其分为对照组(单纯放疗)和观察组(紫杉醇+顺铂方案联合同步放疗),每组各30例,对两组近期疗效、不良反应,以及1年生存率,进行观察和比较。结果与对照组相比,观察组的总有效率、1年生存率均明显升高,P<0.05,差异有统计学意义,而两组不良反应发生率比较,差异没有统计学意义,P>0.05。结论对于中晚期食管癌患者,同步放疗联合紫杉醇+顺铂(TP)方案治疗疗效显著,显著改善患者的预后质量。 Objective To investigate the clinical efficacy of paclitaxel + cisplatin regimen combined with radiotherapy in treatment of advanced esophageal cancer. Methods From March 2011 to March 2012,60 cases of advanced esophageal cancer patients in our hospital,according to the method of random number,which was divided into control group ( radiotherapy) and observation group ( paclitaxel + cisplatin combined with concurrent radiotherapy) ,30 cases in each group,two groups of curative effect,adverse reaction,and the 1 year survival rates,were observed and compared. Results Compared with control group,the total effective rate of observation group,1 year survival rates were significantly increased,P 0. 05,the difference was statistically significant,and the adverse reactions of the two groups were compared,the difference was not statistically significant,P 0. 05. Conclusion For the patients with advanced esophageal cancer,radiotherapy combined with paclitaxel + cisplatin ( TP) regimen in the treatment of a significant effect,significantly improve the prognosis of the patients’quality of.
作者 娄云峰
出处 《中国实用医药》 2013年第24期40-41,共2页 China Practical Medicine
关键词 同步放疗 紫杉醇 顺铂 中晚期食管癌 Radiotherapy Paclitaxel Cisplatin Advanced esophageal cancer
  • 相关文献

参考文献4

二级参考文献11

  • 1姚卫华,路平,花勤亮,吴洁清,苗战会,刘晶,李小瑞.小剂量顺铂和氟尿嘧啶方案同步放射治疗中晚期食管癌[J].中华放射肿瘤学杂志,2005,14(4):262-264. 被引量:24
  • 2仇红艳.同期放化疗综合治疗食管癌临床疗效观察[J].实用癌症杂志,2005,20(5):527-528. 被引量:24
  • 3林通榆 吴海鹰.紫杉醇治疗恶性肿瘸的Ⅱ期临床研究.中华肿瘤杂志,2007,20(3):157-161. 被引量:1
  • 4Katlic MR, Wildins EW, Grillo HC. Three decades of treatment of esophageal squamous carcinoma at the Massahutts Genceral Hospital[J]. J Thorac Cardivasc Surg, 1990,99(5) :929. 被引量:1
  • 5Polee MB,Eskens FA,Van der Burg ME,et al. Phase Ⅱ study of hi-weekly administration of paclitaxel and cisplatin in patients with advanced esophageal cancer[J]. Br J Cancer,2002,86(5) :669. 被引量:1
  • 6Safrah H, Akeman P, Cioffi W, et al. Paelitaxel and concurrent radioation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction[J]. Semin Radiat Oncol, 1999,9(Suppl1) : 53. 被引量:1
  • 7Klanber N, Parangi S, Flynn E, et al. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-Me-thoxyestradiol and paclitaxel [J]. Cancer Res,2007,57 ( 1 ) : 81. 被引量:1
  • 8Petrasch S, Welt A, Reinacher A, et al. Chemotherapy with cisplatin and paelitaxel in patients with locally advanced ,recurrent or metastatic oesophageal cancer[J]. Br J Cancer,2003,78(4) :511. 被引量:1
  • 9Therasse P.Measuring the clinical response.What dose it mean Eur J Cancer,2002,38:1817-1823. 被引量:1
  • 10肖泽芬.食管癌[A].见:殷蔚伯 谷铣之 主编.肿瘤放射治疗学 第3版[C].北京:中国协和医科大学出版社,2002.609. 被引量:28

共引文献38

同被引文献24

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部